Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Cancer Research|July 26, 2000
Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12R Mortarini, A Borri, G Tragni, et al.
The Journal of Cardiovascular Surgery|May 17, 2007
Pneumocephalus after Pancoast's tumor surgery: to be or not to be conservative?P Scanagatta, F Leo, G Veronesi, et al.
Minerva Chirurgica|November 24, 2006
Extended redo sleeve resection for postoperative dehiscence after right upper bronchoplastyF Petrella, G Veronesi, F Leo, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1990
Recombinant interleukin-2 and lymphokine-activated killer cells in renal cancer patients: I. Phenotypic and functional analysis of the peripheral blood mononuclear cellsC Fortis, E Ferrero, C Besana, et al.
AIDS (London, England)|July 1, 1991
B-cell activation during HIV-1 infection. III. Down-regulating effect of mitogensA Amadori, R Zamarchi, M L Veronese, et al.
Human Immunology|January 23, 1998
TCR expression and clonality analysis in peripheral blood and lymph nodes of HIV-infected patientsM Mion, S Indraccolo, F Feroli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanomaE Bajetta, M Del Vecchio, R Mortarini, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of advanced renal cell cancer with sequential intravenous recombinant interleukin-2 and subcutaneous alpha-interferonC Besana, A Borri, E Bucci, et al.
Journal of Clinical Immunology|November 1, 1993
B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsetsS Indraccolo, M Mion, R Zamarchi, et al.
British Heart Journal|February 1, 1994
Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancerG Fragasso, M Tresoldi, R Benti, et al.
Pageof 3